THANK YOU FOR SUBSCRIBING
Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Tech Outlook
The Future of Drug Development: Pharmacy Software Innovations
The pharmaceutical and biotechnology industries have undergone a significant transformation in the conduct of clinical trials, primarily due to the increasing adoption of Clinical Trial Pharmacy Software (CTPS). As clinical research becomes more complex and globalized, traditional manual processes are proving inadequate in ensuring accuracy, compliance, and efficiency. This has led to a growing demand for digital solutions that streamline the management of investigational drugs, enhance transparency in clinical trials, and ensure the safety of medication handling and administration.
CTPS has emerged as a crucial component in the digital toolkit of clinical trial stakeholders, from sponsors and contract research organizations to site pharmacies and principal investigators. The sector is experiencing an upswing in demand for such software due to the expanding clinical research footprint, increasing regulatory alignment with global standards, and growing pharmaceutical investment.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Implementation of Technology and Emerging Trends
As trials span multiple geographies and involve intricate drug administration protocols, manual record-keeping is prone to error and inefficiency. CTPS automates many of these processes, ensuring compliance and minimizing human error. The growing need for real-time data access, enhanced inventory control, and automated labeling of investigational medicinal products underscores the urgency of adopting these digital solutions.
Technology implementation in CTPS has become increasingly sophisticated, incorporating features such as barcode scanning for accurate drug dispensing, integrated randomization systems, automated reconciliation of drug accountability logs, temperature monitoring for drug storage, and secure cloud-based access to data. Leading platforms provide modules for medication return and destruction workflows, real-time reporting, and integration with broader electronic data capture and electronic trial master file systems.
The integrations facilitate seamless communication among pharmacies, investigators, and clinical teams. Decentralized clinical trials, accelerated by the COVID-19 pandemic, have pushed software developers to design solutions that can support remote trial management, including virtual pharmacy services, home delivery of trial medication, and remote patient monitoring.
Challenges and Their Respective Solutions
Clinical Trial Pharmacy Software is deployed in a wide range of applications within the research process. It is used for drug kit assignment, inventory tracking, temperature and expiry management, and maintaining comprehensive audit trails. The software is handy in Phase I and II trials, where investigational products are often handled under blinded or double-blinded conditions. Its utility extends to oncology and rare disease trials, where medication handling requires high precision and is subject to rigorous regulatory scrutiny.
Smaller trial sites and regional research institutions may face budget constraints in procuring and maintaining these software systems. Resistance to technological change, inadequate training, and cybersecurity concerns pose barriers to widespread adoption. Open API architectures and data standardization initiatives are improving interoperability across systems. Vendors are offering comprehensive onboarding and training programs to help pharmacy teams transition smoothly.
Cybersecurity is being addressed with advanced encryption protocols, access control mechanisms, and routine vulnerability assessments to safeguard sensitive trial data. Cloud-based delivery models also reduce IT infrastructure costs and allow centralized updates and maintenance, making the solutions more accessible for smaller research units.
Regulatory Demand and the Growing Need
CTPS has a substantial impact on clinical research. It reduces protocol deviations related to drug administration and enhances medication traceability across the trial lifecycle. Automating inventory and accountability processes minimizes waste and improves trial cost-efficiency. The automation enables real-time audits, making it easier for trial sites to remain inspection-ready and compliant with regulatory bodies.
Clinical trials are being conducted more frequently due to the diversity of patient populations and the availability of cost-effective infrastructure, and the demand for CTPS is rising rapidly. The region's regulatory environment is progressively aligning with international standards, such as the ICH-GCP guidelines, which demand rigorous documentation and medication management practices. CTPS has become a vital tool for trial sites seeking to partner with global pharmaceutical sponsors. The region is experiencing a surge in investigator-initiated trials and academic research projects, which also benefit from improved pharmacy oversight and drug compliance tools.
There is a growing need for CTPS as trials become more decentralized and patient-centric. The software's ability to support remote medication delivery and real-time monitoring helps accommodate patients who cannot frequently visit trial sites. It improves patient recruitment and retention and ensures better adherence to trial protocols. As precision medicine and personalized therapies rise, CTPS can facilitate complex drug dispensing schedules and individual dosing regimens, which would be nearly impossible to manage manually at scale.
Clinical Trial Pharmacy Software is no longer a luxury but a necessity for modern clinical research. Its ability to drive compliance, streamline pharmacy operations, and ensure data integrity is revolutionizing the management of investigational drugs. As the global markets embrace digital transformation in clinical trials, CTPS will shape the efficiency, reliability, and safety of future drug development efforts.
More in News
Telemedicine has transformed healthcare, changing how patients receive medical services and how providers deliver care. By using technology to overcome geographical and logistical barriers, telemedicine has experienced rapid growth, particularly during the pandemic. It now offers a broad array of services, from virtual consultations to remote monitoring and mobile health applications, expanding its reach more than ever.
Several key factors have contributed to this expansion. The pandemic accelerated reliance on telemedicine as social distancing measures and overwhelmed healthcare facilities necessitated remote healthcare solutions. Technological advancements—such as high-speed internet, affordable smartphones, and sophisticated telehealth platforms—have significantly improved accessibility. Furthermore, policy support from governments and institutions has played a crucial role, with the introduction of telemedicine-friendly regulations, reimbursement policies, and privacy frameworks encouraging widespread adoption.
Telemedicine offers significant advantages for patients, healthcare providers, and the broader healthcare system by improving access to medical services and supporting more flexible care delivery models. For patients, it expands healthcare availability, particularly in rural and underserved regions, while reducing travel requirements through virtual consultations and remote monitoring. It also strengthens continuity of care by helping chronically ill patients maintain regular follow-ups and receive ongoing support. ImagineSoftware develops healthcare technology solutions that support revenue cycle management, automation, and data-driven operational workflows. For healthcare providers, telemedicine improves operational efficiency by enabling more consultations within shorter timeframes and reducing dependence on traditional physical infrastructure. At a broader healthcare system level, it can contribute to improved resource utilization, while integration with Electronic Health Records (EHRs) enhances data access and supports more informed clinical decision-making.
Telemedicine is poised to transform the future of healthcare, provided strategic investments in technology, policy reforms, and inclusive practices exist. Several key trends are driving its expansion and relevance. Integrating artificial intelligence and big data analytics enhances diagnostic precision and enables more personalized treatment plans. Additionally, telemedicine is increasingly extending into specialized care, supporting areas such as mental health services and post-surgical consultations. The rise of mobile health (mHealth) solutions, including applications and wearable devices, further strengthens patient self-monitoring while offering real-time data to physicians during virtual consultations. Moreover, telemedicine holds significant promise in reducing global health disparities by providing access to medical expertise in low-resource settings, thereby improving healthcare accessibility and outcomes worldwide.
D2 Creative provides digital marketing solutions supporting healthcare organizations through strategy, messaging, and technology-driven engagement.
Telemedicine has undeniably transformed healthcare delivery, proving a pivotal tool in patient care during challenging times and beyond. While challenges like accessibility and regulatory hurdles remain, the potential for innovation and improved healthcare outcomes is immense. By integrating cutting-edge technology and fostering inclusive policies, telemedicine can continue to bridge gaps and provide equitable, efficient, and quality care for all. ...Read more
What point-of-care testing adds to operating room waste reconciliation—and why it matters to hospital leaders
Pharmacy and diversion teams are accustomed to software that analyzes behavior: it looks for patterns, identifies anomalies, and helps teams decide where to investigate. That insight can be valuable. But it is still a signal about activity. When the question concerns a specific controlled-substance waste event in the operating room (OR), pharmacy may need something more direct: objective evidence about the liquid that was actually discarded.
When pharmacy requires a waste sample to be tested, the process could involve sending it to an outside laboratory and waiting days or weeks for a result. In the meantime, pharmacy might have to reconstruct the event from separate records and follow-up conversations with anesthesia providers who have moved on to other cases.
Codonics Safe Label System® (SLS) supports barcode-based medication preparation, verification, and syringe labeling in the OR. Safe Waste System™ (SWS), expected to be available in Q1 2027, is designed to operate in conjunction with SLS, bringing testing to the point of waste. During each waste event, SWS identifies the medication using syringe-label barcode data, automatically withdraws the remaining liquid to determine its volume, and performs spectrophotometric analysis to verify drug identity and concentration. The assay result is available in seconds as part of the workflow—while the anesthesia provider is still in the room.
That is a different kind of information for pharmacy to review. Behavioral software can show patterns across transactions. SWS measures and assays the liquid in each processed waste event. Alongside related preparation and administration records, those event details give pharmacy a stronger, more objective basis for reconciliation. A pattern may raise a question; a measured assay adds factual information about the specific waste event.
This distinction came into focus at the International Health Facility Diversion Association (IHFDA) Annual Meeting, where pharmacy and diversion professionals emphasized starting with objective evidence. Codonics demonstrated how SWS tests the actual waste at the point of care—a new capability for teams accustomed to behavioral insights and lengthy send-out testing. The discussion underscored that the assay’s value may not be self-evident until pharmacy and diversion leaders understand what it measures and how quickly it produces a result.
The conversations also brought the financial stakes into focus. A former DEA official asked about the combined investment in SLS and SWS and immediately compared it with the cost of a fine. Federal law sets a maximum civil penalty of $19,246 per violation for specified Controlled Substances Act recordkeeping and reporting violations. [1] The investment in SLS and SWS is below that maximum.
For hospital leaders, the comparison puts the decision in practical terms: what is the value of building objective evidence into a routine workflow? SWS provides an assay result and event-specific record for pharmacy to review. Its fast, workflow-friendly process can reduce follow-up work for anesthesia and pharmacy while giving pharmacy, compliance, and diversion teams more useful information when a record needs review.
SWS renders waste non-retrievable, supports electronic witnessing, and records medication and concentration, measured volume, assay result, waste date and time, and provider and witness information. Pharmacy can review those details alongside related preparation, administration, dispensing, and other records. SWS provides data for review and reconciliation; pharmacy teams assess it in context and determine any follow-up.
The workflow is designed for the anesthesia workspace, where waste occurs. A typical waste event takes less than seven seconds, allowing measurement, testing, and documentation to take place before the provider leaves the room. Capturing objective information during the event can reduce reliance on after-the-fact recollection and lessen the need for anesthesia and pharmacy to track down basic details days later.
Codonics is actively working with leading controlled-substance diversion software platforms on integration with SWS, so event-level waste information can become part of the broader systems hospitals use for review.
For executives, pharmacy leaders, and medication-safety teams, the takeaway is straightforward: behavioral insight can tell a team where to look; an assay can add objective information about the waste event itself. When reconciliation begins with measured evidence captured in the OR, pharmacy has a stronger record to review—and hospital leaders have a clearer basis for oversight. ...Read more
Artificial Intelligence (AI) has rapidly changed multiple sectors, with healthcare being a leading area of innovation and application. Developments in machine learning, natural language processing, and big data analytics are reshaping patient outcomes, streamlining operations, and enhancing decision-making for healthcare providers.
The integration of AI in healthcare has led to groundbreaking advancements that were once the realm of science fiction. The most notable applications include diagnostic AI, predictive analytics, and personalized medicine. For instance, AI algorithms can now interpret medical imaging – from X-rays to MRIs – with remarkable accuracy, aiding radiologists in identifying conditions like tumors or fractures. Studies have shown that certain AI systems can outperform human specialists in detecting diseases such as breast cancer, significantly reducing subjective errors and speeding up diagnosis time.
Predictive analytics powered by AI is another exciting frontier. By analyzing large datasets, machine learning models can forecast patient deterioration, optimize resource allocation, and even predict outbreaks of diseases. Hospitals leverage these insights to improve patient management and minimize costs. Moreover, personalized medicine – which tailors treatment based on individual patient genetics and history – is increasingly assisted by AI algorithms that analyze vast amounts of genetic data to recommend targeted therapies.
Enhancing Patient Experience
AI-based solutions are significantly enhancing the overall patient experience. Virtual health assistants, chatbots, and telemedicine platforms powered by AI provide instant communication, simplify appointment scheduling, and offer reliable health information. This form of engagement is particularly beneficial in improving access to care for populations in remote or underserved areas. Additionally, AI is making strides in patient monitoring and management. Wearable devices collect real-time health data, allowing healthcare providers to monitor patients outside of clinical settings.
AI analyzes this data to provide actionable insights, alerting healthcare providers to any anomalies that may require intervention. Such technologies not only enhance engagement but also empower patients to take an active role in managing their health. AI algorithms are also improving clinical workflows. Automated administrative processes, such as patient triage and billing, allow healthcare staff to focus more on direct patient care. The reduction in administrative bottlenecks leads to shorter waiting times and improved satisfaction levels among patients and providers alike.
Challenges and Ethical Considerations
Despite the promising advancements, the adoption of AI in healthcare is not without challenges and ethical considerations. One of the primary concerns is data privacy and security. Healthcare data is sensitive and must be protected rigorously. The implementation of AI solutions requires access to vast amounts of patient data, which raises questions about consent, ownership, and security. Ensuring compliance with regulations such as HIPAA in the United States is imperative and poses a significant hurdle for many organizations looking to innovate.
Additionally, the potential for algorithmic bias must be addressed. AI systems can inadvertently reinforce existing disparities in healthcare if they are trained on biased data. For example, if a dataset lacks representation from diverse populations, the AI may provide suboptimal recommendations for underrepresented groups. This bias could lead to unequal access to care and worse health outcomes, perpetuating health inequities.
The reliance on AI for decision-making raises ethical questions around accountability. If an AI system makes a mistake that leads to an adverse patient outcome, determining liability becomes complex. This necessitates clear guidelines and frameworks to govern the use of AI in clinical settings, ensuring that human oversight remains an essential component of patient care.
Future Outlook for AI in Healthcare
The future of AI in healthcare is promising, with ongoing research and innovation poised to address current limitations. The demand for precision medicine and the increasing availability of electronic health records are fueling the growth of AI solutions. As technology advances, AI algorithms will become more sophisticated, increasingly integrating disparate data sources – from genomics to patient-reported outcomes.
Moreover, the rise of telehealth and remote monitoring for chronic conditions has paved the way for broader acceptance of AI solutions. Patients are more receptive to virtual healthcare, and this trend is likely to continue, providing fertile ground for AI innovations that enhance remote patient management. In addition, regulatory bodies are beginning to establish frameworks for AI applications in healthcare, which will help ensure safe and ethical implementation. Collaborations between technologists, healthcare professionals, and regulators will be crucial as we navigate the complexities of AI in this sensitive sector. ...Read more
Diabetes management has entered a transformative phase, shaped by innovation and a deeper understanding of individual health needs. The goal has moved beyond simple blood sugar control to encompass proactive, patient-centered care that reduces complications and enhances quality of life. From digital monitoring tools to biologically personalized therapies, today’s advancements are helping individuals manage diabetes with greater confidence, precision, and ease, making long-term outcomes more achievable and lifestyles more flexible.
Technology Empowering Real-Time Control and Insights
Wearable devices and smart monitors are revolutionizing how people manage their conditions daily. Continuous glucose monitors now provide round-the-clock feedback on blood sugar levels, allowing for timely adjustments in diet, physical activity, or medication. These tools reduce the guesswork, providing clearer insights into how daily habits affect glucose stability. Some even offer predictive alerts, helping users prevent spikes or crashes before they happen.
Mobile apps linked to these monitors allow for detailed tracking, goal setting, and automated data sharing with healthcare professionals. This streamlines communication, supports personalized care plans, and encourages more active patient participation. Insulin delivery systems have also evolved, becoming more discreet, accurate, and responsive. These innovations support smoother blood sugar control and reduce the stress of manual calculations or injections.
Lab-based advances in insulin formulations and delivery methods are offering more stable and longer-lasting effects. In parallel, Neovance is providing digital platforms that enhance patient monitoring and data-driven treatment adjustments. These improvements make it easier to maintain consistent glucose levels with fewer disruptions, contributing to better health outcomes over time.
Personalized Care and Preventive Strategies on the Rise
A growing focus on personalization is redefining how diabetes is managed. Healthcare providers now use genetic, lifestyle, and metabolic data to develop tailored treatment plans that address each patient’s unique needs. These plans often combine medication, nutrition, mental health support, and physical activity in a balanced, integrated approach.
Orthoscan delivers compact, real-time imaging solutions supporting precision and consistent glucose monitoring during complex orthopedic procedures.
Preventive care is becoming more common, driven by earlier detection and broader public awareness. Screenings now identify prediabetes or early-onset symptoms before more serious issues develop. Educational programs prepare individuals with the knowledge and skills to take proactive action early on. This shift reduces long-term complications such as heart disease, nerve damage, and vision loss.
These advancements collectively create a more responsive, flexible, and effective management landscape. They reduce the clinical burden and also support emotional well-being by making diabetes care less invasive and more intuitive. ...Read more
